Because two things are happening at once and they push in opposite directions.<\/p>\n
Upward:<\/strong> a modest increase in resting heart rate is a recognized effect of this medication class.<\/p>\n Downward:<\/strong> losing weight and improving fitness both tend to lower resting heart rate, often substantially over months.<\/p>\n Which one dominates depends on where you are in treatment, how much weight you have lost, and what else has changed. Some people see their resting rate rise slightly in the first months and then fall below where it started. Others see a steady decline throughout. Both are within the expected range.<\/p>\n A modest rise in resting heart rate has been documented across GLP-1 medications. It is generally small and it has been examined alongside the broader cardiovascular picture, which for semaglutide has been studied in large outcome trials and has been favourable overall.<\/p>\n That context matters. A small increase in resting rate sits inside a cardiovascular profile that has been reassuring in the aggregate, which is why this is monitored rather than treated as alarming.<\/p>\n Carrying less weight means the heart does less work at rest. Improving fitness lowers resting rate further, and better sleep, including improvements in sleep apnea, contributes as well.<\/p>\n Over months this effect is frequently the larger of the two, which is why many people end up with a lower resting heart rate than they started with despite the class effect.<\/p>\n Consider this scenario: a patient with a wearable sees their resting rate rise by a few beats in the first two months and worries. By month eight it has fallen well below their pre-treatment baseline, having tracked their weight down. The early rise was real and it was not the whole story.<\/p>\n Most people asking this are asking because a watch told them, which is genuinely new. Two things worth knowing.<\/p>\n Consumer wearables are useful for trends, not precision.<\/strong> A few beats of difference between devices, or between nights, is not meaningful. What is meaningful is a sustained change over weeks.<\/p>\n Confounders are everywhere.<\/strong> Alcohol, poor sleep, illness, dehydration, caffeine, stress, and hard exercise all raise resting heart rate, and several of those are more likely during a period of dietary change.<\/p>\n Look at your multi-week trend rather than reacting to individual days.<\/p>\n Before attributing a rise to the medication, check these:<\/p>\n Dehydration.<\/strong> Common and under-recognized on this medication, because appetite suppression blunts thirst. A low circulating volume raises heart rate directly. Our guide on electrolytes on semaglutide<\/a> covers why hydration matters more here than most people expect.<\/p>\n Inadequate intake.<\/strong> Eating very little can raise resting rate.<\/p>\n Anemia<\/strong>, which produces a compensatory rise and is plausible when intake has been low for months.<\/p>\n Thyroid changes.<\/strong><\/p>\n Caffeine on a much smaller food intake<\/strong>, which is not the same exposure it used to be.<\/p>\n Anxiety or poor sleep.<\/strong><\/p>\n Several of these are testable, and if your rate has risen and stayed up, testing is a better use of your time than speculating.<\/p>\n Track the trend rather than the day.<\/strong> Weeks, not mornings.<\/p>\n Check your actual pulse manually<\/strong> occasionally, to sanity-check the device.<\/p>\n Hydrate on a schedule<\/strong>, since thirst is unreliable here.<\/p>\n Eat adequately.<\/strong> Under-eating contributes and is common.<\/p>\n Note it for your next appointment<\/strong>, with actual numbers rather than an impression.<\/p>\n Bring your medication list<\/strong>, including anything compounded, which may not appear in pharmacy records.<\/p>\n Contact your provider if:<\/p>\n Blood pressure medication in particular frequently needs reviewing during weight loss, because a dose that was correct at a higher weight can become too strong. Our guide on how GLP-1 medications affect blood pressure over time<\/a> covers what changes.<\/p>\n Those are not questions to work out from a wearable.<\/p>\n Worth keeping in view. The reason a modest resting heart rate change is monitored rather than alarming is that the overall cardiovascular data for this class has been favourable, and the metabolic improvements that come with sustained weight loss, including blood pressure, cholesterol, and glucose, generally move in a helpful direction.<\/p>\n Our guides on Ozempic and heart health<\/a> and GLP-1 medications and cholesterol<\/a> cover what to expect.<\/p>\n Two forces: a modest class-related rise, and a larger downward pull from weight loss and fitness. Which wins depends on where you are. Watch the multi-week trend rather than daily readings, rule out dehydration and inadequate intake first, and take actual numbers to your provider. A sustained rise, palpitations, or symptoms alongside it warrants a proper look, and chest pain or fainting warrants urgent care.<\/p>\nThe class effect<\/h2>\n
Why weight loss pulls the other way<\/h2>\n
Wearables changed this question<\/h2>\n
What else could be driving it up<\/h2>\n
What to do about it<\/h2>\n
When to contact your provider<\/h2>\n
\n
Seek urgent care for<\/h2>\n
\n
The bigger cardiovascular picture<\/h2>\n
The short version<\/h2>\n